Recent studies have linked glucagon-like peptide-1 (GLP-1) receptor agonist medications, such as Zepbound and Ozempic , to potential heart health benefits, including lower risk for cardiovascular diseases , such as heart attack and stroke , as well as helping lower blood pressure and cholesterol levels . Now a new study published in the journal Nature Communications adds to what we know about the possible cardiovascular benefits of GLP-1 medications.
In this study, researchers found using a mouse model that GLP-1 drugs might assist with heart attack recovery by lowering a person’s risk of developing major complications that can increase a person’s chances of hospital admission for heart failure or death. For this study, researchers used a mouse model to examine how GLP-1s might impact major heart complications after heart attack.
Medical News Today published a clinical update in Research Highlights on 07 Mar 2026.
The item focuses on Could GLP-1 drugs cut the risk of complications after a heart attack?.
Review the original article for the full source wording and details.